Are You Expected to Deliver Even Bigger Profit Margins from Your eMarketing and eDetailing Activities, and Prove that you Have?
All types of pharmaceutical marketing should be subject to careful analysis of costs and financial return. EMarketing and eDetailing must not be treated differently. Measuring the return on investment (ROI) of an eMarketing and eDetailing programme is essential to ensure success. Pharmaceuticals marketers must avoid the temptation of using past marketing plans and adapting them slightly without taking into account the wider picture. So far the limited number of studies into the impact of eDetailing have produced positive results. Although there are potentially a myriad of benefits from an eMarketing or eDetailing programme, any implementation of a system needs judged by bottom-line improvement. In the case of eDetailing this probably means increasing the numbers of prescriptions written or substantially reducing costs of a sales and marketing operation. It is usual business practice to calculate the return-on-investment on software investment and an eDetailing system should be no different. All relevant metrics must be measured to ensure that there is, in fact, a significant return of investment. Clearly the overriding objective of any form of eDetailing activity is to increase the number of prescriptions written, while reducing costs.
Optimize eDetailing Return With the Most Sophisticated Tools Currently Available
94.8 analytics provides a solution to these issues that has the
highest degree of accuracy found in the market today. 94.8 analytics
is a sophisticated system that identifies the components of the
mix currently (not historically) driving market performance, then
calculates optimal promotional mix and budget allocation and tests
the results to validate approach. From this you will:
• Know which eDetailing approach is providing the strongest return for your brand
• Know what content within the eDetail is providing the strongest returns
• Understand the impact of different edetailing frequencies to know which is optimal for maximum impact
• Know how much market share impact the eDetailing is having and which elements of the eDetail are providing this
• Know how to change the eDetail to provide more return moving forward
• Match eDetailing strategy to your brand and company's best economic returns & capabilities
• Change the process from one based on the past to a dynamic, forward-looking
strategy
• Ensure that the analysis is part of a comprehensive cross-functional
process
• Integrate into management systems to allow rapid response to internal
and external change
• Give senior management the confidence to support a brand with
the right resources
Case studies available upon request.
Are You in This List?
• VP Sales and Marketing
• Sales and Marketing Directors
• eBusiness Directors
• eBusiness Managers
• Group Brand Managers
• Senior Product Managers
• Senior Brand Managers
• Agency Directors Needing to show ROI to their pharma brand clients
Receive Case Studies Now
CONTACT US TODAY FOR YOUR FREE CASE STUDIES AND DEMONSTRATION OF 94.8 ANALYTICS IN ACTION WITH REAL PHARMACEUTICAL BRANDS.
Why Invest in these Analytics?
Independent research on our system showed an accuracy of 94.8%
over several years.
Are you arguing for your eDetailing budget against sales force budget or against other eBusiness budgets and want an evidence based approach to support your spend and help you improve the return from the eDetail? This approach will solve your problems completely.
CONTACT US
TODAY FOR ANY FURTHER INFORMATION ON ANY ASPECT OR TO SCHEDULE A MEETING FOR A DEMONSTRATION.
'The
7 Secrets